GSA: An Independent Development Algorithm for Calling Copy Number and Detecting Homologous Recombination Deficiency (HRD) from Target Capture Sequencing
Dongju CheniD, Minghui Shao, Pei MengiD, Chunli WangiD, Qi LiiD, Yuhang CaiiD, Chengcheng SongiD, Xi WangiD, Taiping Shi
Abstract
BackgroundThe gain or loss of large chromosomal regions or even whole chromosomes is termed as genomic scarring and can be observed as copy number variations resulting from the failure of DNA damage repair. ResultsIn this study, a new algorithm called Genomic Scar Analysis (GSA) has developed and validated to calculate homologous recombination deficiency (HRD) score. The two critical submodules were tree recursion (TR) segmentation and filtering, and the estimation and correction of the tumor purity and ploidy. Then, this study evaluated the rationality of segmentation and genotype identification by the GSA algorithm and compared with other two algorithms, PureCN and ASCAT, found that the segmentation result of GSA algorithm was more logical. In addition, the results indicated that the GSA algorithm had an excellent predictive effect on tumor purity and ploidy, if the tumor purity was more than 20%. Furtherly, this study evaluated the HRD scores and BRCA1/2 deficiency status of 195 clinical samples, and the results indicated that the accuracy was 0.98 (comparing with Affymetrix OncoScan assay) and the sensitivity was 95.2% (comparing with BRCA1/2 deficiency status), both were well-behaved. Finally, HRD scores and 16 genes mutations (TP53 and 15 HRR pathway genes) were analyzed in 17 cell lines, the results showed that there was higher frequency in HRR pathway genes in high HRD score samples. ConclusionsThis new algorithm, named as GSA, could effectively and accurately calculate the purity and ploidy of tumor samples through NGS data, and then reflect the degree of genomic instability and large-scale copy number variations of tumor samples.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 21
- FWCI
- 1.79
- Field percentile
- top 15%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Optimized detection of allelic imbalances specific for homologous recombination deficiency improves the prediction of clinical outcomes in cancer
F. Perez-Villatoro, J. Oikkonen, … A. Farkkila·bioRxiv·Aug 19, 2021
- IdentifiHR: predicting homologous recombination deficiency in high-grade serous ovarian carcinoma using gene expression
Ashley L. Weir, Samuel C. Lee, … Nadia M. Davidson·Communications MedicinePeer-reviewed·Jan 14, 2026
- Benchmarking homologous recombination deficiency algorithms for prediction of clinical outcome in ovarian cancer
Lasse Ringsted Mark, Inge Søkilde Pedersen, … Martin Bøgsted·medRxiv·Oct 8, 2025
- DirectHRD enables sensitive scar-based classification of homologous recombination deficiency (HRD)
Ruolin Liu, Eugenia Roberts, … Viktor A. Adalsteinsson·Nucleic Acids ResearchPeer-reviewed·Apr 17, 2025
- HRDex: a tool for deriving homologous recombination deficiency (HRD) scores from whole exome sequencing data
John B. Pluta, Ryan M. Hausler, … Kara N. Maxwell·bioRxiv·Sep 8, 2022
- Homologous recombination deficiency prediction from whole slide images using label refinement and foundation-model benchmarking in ovarian cancer
Nauman Ali Shah, Makhdoom Sarwar, Ehsan Ullah·bioRxiv·Jun 30, 2026